Inhaltsangabe
1. Selection criteria based on Radiation Oncology perspective for definitive treatment approaches in urological cancers
2. Radiological imaging in urological cancers
3. The role of functional imaging in urological cancers
4. Surgery in renal cell cancer
5. Systemic therapies in renal cell cancer
6. The role of radiotherapy in renal cell cancer
7. Screening of prostate cancer: Pros and Cons
8. Risk groupings in prostate cancer
9. Active surveillance in low risk cancer: Pros and Cons10. Alternative focal therapies in low-risk prostate cancer: HiFU and Cryotherapy
11. Robotic surgery in prostate cancer
12. Radical retropubic prostatectomy in low-high risk prostate cancer
13. Guidelines for the delineation of primary tumor target volume in prostate cancer
14. Guidelines for the delineation of lymphatic target volumes in prostate cancer
15. Modern radiotherapy techniques in prostate cancers
16. Protontherapy for prostate cancer
17. Brachytherapy for prostate cancer
18. Stereotactic body radiotherapy for prostate cancer
19. The role of hormonal therapies and radiotherapy in prostate cancer
20. The role of hormonal therapies after surgery21. PSA after radiotherapy: Biochemical failure and PSA bounce
22. Adjuvant and Salvage Radiotherapy in prostate cancer
23. Reirradiation in prostate cancer24. Systemic chemotherapies in the management of prostate cancer
25. Translational research and immunotherapy in prostate cancer
26. Surgery in superficial and invasive bladder cancer
27. Target volume delineation guidelines in bladder cancer
28. Bladder preservation therapies in bladder cancer
29. Systemic chemotherapies in bladder cancers
30. Translational research and immunotherapy in bladder cancer
31. Radiolabelled targeted therapies in urological tumors
32. Radiation induced toxicity and related management strategies on urological malignancies
33. Quality assurance of modern radiotherapy techniques in urological malignancies
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
